Pharmaceutical preparations for the treatment and prevention of mitochondrial diseases and disorders; pharmaceutical preparations for the treatment of genetic diseases and disorders; anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of liver and kidney diseases and disorders; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma; pharmaceutical preparations for the prevention and treatment of fibrosis

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 98264911

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 323344-20000

44D Filed

44D Current

44E filed

44E Current

66A Filed

66A Current

Current Basis

No Basis

Legal History

Status Date	Action Taken
20^th Nov 2024	EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
17^th Sep 2024	ABANDONMENT - AFTER PUBLICATION
17^th Sep 2024	ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
16^th Sep 2024	TEAS EXPRESS ABANDONMENT RECEIVED
16^th Aug 2024	EXTENSION OF TIME TO OPPOSE RECEIVED
15^th Aug 2024	TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
15^th Aug 2024	ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
15^th Aug 2024	TEAS CHANGE OF CORRESPONDENCE RECEIVED
23^rd Jul 2024	OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
23^rd Jul 2024	PUBLISHED FOR OPPOSITION

ABMYVO

Classification Information

Class [005]Pharmaceutical Products